Phibro Animal Health Corp (PAHC) EPS Estimated At $0.38

November 7, 2017 - By Vivian Currie

 Phibro Animal Health Corp (PAHC) EPS Estimated At $0.38
Investors sentiment increased to 1.92 in Q2 2017. Its up 0.01, from 1.91 in 2017Q1. It is positive, as 13 investors sold Phibro Animal Health Corp shares while 36 reduced holdings. 30 funds opened positions while 64 raised stakes. 19.08 million shares or 2.17% more from 18.67 million shares in 2017Q1 were reported.
Pnc Fincl Services Gru stated it has 0% of its portfolio in Phibro Animal Health Corp (NASDAQ:PAHC). Polaris Capital Mngmt Limited Liability owns 76,800 shares. State Of Wisconsin Invest Board has invested 0% of its portfolio in Phibro Animal Health Corp (NASDAQ:PAHC). Denali Advsrs Lc accumulated 79 shares. Tfs Cap Ltd Liability Com owns 0.62% invested in Phibro Animal Health Corp (NASDAQ:PAHC) for 42,591 shares. Bnp Paribas Arbitrage invested 0% of its portfolio in Phibro Animal Health Corp (NASDAQ:PAHC). Citigroup has 0% invested in Phibro Animal Health Corp (NASDAQ:PAHC) for 74,682 shares. Ameriprise Fincl Inc accumulated 339,996 shares. Denver Invest Advsr Limited Liability Company reported 1.13% of its portfolio in Phibro Animal Health Corp (NASDAQ:PAHC). Citadel Advsrs Lc holds 0% or 18,699 shares. Ubs Asset Mngmt Americas Incorporated reported 58 shares or 0% of all its holdings. Moreover, Bankshares Of America Corporation De has 0% invested in Phibro Animal Health Corp (NASDAQ:PAHC) for 113,650 shares. California Pub Employees Retirement Systems owns 41,100 shares or 0% of their US portfolio. Tiaa Cref Mgmt Ltd Liability Co owns 168,784 shares. D E Shaw invested in 0% or 10,463 shares.

Since May 9, 2017, it had 0 buys, and 10 selling transactions for $14.10 million activity. The insider BFI Co. – LLC sold $1.66 million. 48,000 shares were sold by BENDHEIM JACK, worth $1.71 million on Wednesday, June 7. $290,264 worth of Phibro Animal Health Corp (NASDAQ:PAHC) was sold by Carlson Gerald K. The insider Dagger Thomas G sold 8,000 shares worth $257,040.

Analysts await Phibro Animal Health Corp (NASDAQ:PAHC) to report earnings on November, 8. They expect $0.38 earnings per share, up 5.56 % or $0.02 from last year’s $0.36 per share. PAHC’s profit will be $15.18M for 23.88 P/E if the $0.38 EPS becomes a reality. After $0.39 actual earnings per share reported by Phibro Animal Health Corp for the previous quarter, Wall Street now forecasts -2.56 % negative EPS growth. About 79,993 shares traded. Phibro Animal Health Corp (NASDAQ:PAHC) has risen 89.87% since November 7, 2016 and is uptrending. It has outperformed by 73.17% the S&P500.

Phibro Animal Health Corp (NASDAQ:PAHC) Ratings Coverage

Among 8 analysts covering Philbro Animal Health (NASDAQ:PAHC), 4 have Buy rating, 3 Sell and 1 Hold. Therefore 50% are positive. Philbro Animal Health has $42.0 highest and $31 lowest target. $36’s average target is -0.83% below currents $36.3 stock price. Philbro Animal Health had 16 analyst reports since September 30, 2015 according to SRatingsIntel. The firm has “Buy” rating by Piper Jaffray given on Thursday, August 31. The stock of Phibro Animal Health Corp (NASDAQ:PAHC) has “Buy” rating given on Friday, October 6 by Piper Jaffray. Piper Jaffray maintained Phibro Animal Health Corp (NASDAQ:PAHC) on Friday, August 25 with “Buy” rating. Macquarie Research downgraded the stock to “Underperform” rating in Friday, November 11 report. The rating was downgraded by Credit Suisse to “Hold” on Friday, June 2. Barclays Capital downgraded the stock to “Underweight” rating in Monday, January 18 report. The firm has “Overweight” rating by KeyBanc Capital Markets given on Tuesday, October 13. The rating was initiated by Credit Suisse on Thursday, February 4 with “Outperform”. As per Thursday, November 10, the company rating was downgraded by Gabelli. The firm has “Underperform” rating given on Wednesday, August 23 by Bank of America.

Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. The company has market cap of $1.45 billion. The Firm operates in three divisions, which include Animal Health, Mineral Nutrition and Performance Products. It has a 22.5 P/E ratio. The Firm offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

More notable recent Phibro Animal Health Corp (NASDAQ:PAHC) news were published by: Prnewswire.com which released: “Phibro Animal Health Corporation to Acquire Biotay SA in Argentina” on September 11, 2017, also Globenewswire.com with their article: “Phibro Animal Health Corporation Reports First Quarter” published on November 06, 2017, Nasdaq.com published: “Phibro Animal Health & Zydus Cadila Plan to Expand in India” on July 07, 2017. More interesting news about Phibro Animal Health Corp (NASDAQ:PAHC) were released by: Seekingalpha.com and their article: “Phibro Animal Health’s (PAHC) CEO Jack Bendheim on Q4 2017 Results – Earnings …” published on August 31, 2017 as well as Seekingalpha.com‘s news article titled: “Phibro Animal Health: Good Company, Good Performance, Questionable Price” with publication date: February 23, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.